AU2001242523A1 - Aminophenyl pyrimidone derivatives - Google Patents

Aminophenyl pyrimidone derivatives

Info

Publication number
AU2001242523A1
AU2001242523A1 AU2001242523A AU4252301A AU2001242523A1 AU 2001242523 A1 AU2001242523 A1 AU 2001242523A1 AU 2001242523 A AU2001242523 A AU 2001242523A AU 4252301 A AU4252301 A AU 4252301A AU 2001242523 A1 AU2001242523 A1 AU 2001242523A1
Authority
AU
Australia
Prior art keywords
aminophenyl
pyrimidone derivatives
pyrimidone
derivatives
aminophenyl pyrimidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242523A
Other languages
English (en)
Inventor
Hugues D'orchymont
Karine Lavrador
Bruno Schoentjes
Viviane Van Dorsselaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Mitsubishi Pharma Corp
Original Assignee
Sanofi Synthelabo SA
Mitsubishi Tokyo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA, Mitsubishi Tokyo Pharmaceuticals Inc filed Critical Sanofi Synthelabo SA
Publication of AU2001242523A1 publication Critical patent/AU2001242523A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001242523A 2000-03-23 2001-03-22 Aminophenyl pyrimidone derivatives Abandoned AU2001242523A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00400807 2000-03-23
EP00400807A EP1136485A1 (fr) 2000-03-23 2000-03-23 Dérivés d' aminophénylpyrimidinone
PCT/EP2001/003637 WO2001070726A1 (fr) 2000-03-23 2001-03-22 Derives d'aminophenyl pyrimidone

Publications (1)

Publication Number Publication Date
AU2001242523A1 true AU2001242523A1 (en) 2001-10-03

Family

ID=8173611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242523A Abandoned AU2001242523A1 (en) 2000-03-23 2001-03-22 Aminophenyl pyrimidone derivatives

Country Status (4)

Country Link
EP (1) EP1136485A1 (fr)
AR (1) AR028282A1 (fr)
AU (1) AU2001242523A1 (fr)
WO (1) WO2001070726A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003282976A1 (en) 2002-10-21 2004-05-13 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1885454A2 (fr) 2005-05-04 2008-02-13 DeveloGen Aktiengesellschaft Utilisation des inhibiteurs gsk-3 dans la prevention et le traitement des maladies auto-immunes pancreatiques
CA2620333A1 (fr) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenese par modulation du recepteur muscarinique
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
EP2377530A3 (fr) 2005-10-21 2012-06-20 Braincells, Inc. Modulation de neurogénèse par inhibition PDE
WO2007053596A1 (fr) 2005-10-31 2007-05-10 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SG10201507362TA (en) 2009-08-05 2015-10-29 Intra Cellular Therapies Inc Novel Regulatory Proteins And Inhibitors
SI2810937T1 (sl) * 2012-01-31 2017-01-31 Daiichi Sankyo Company, Limited Derivat piridona
TWI690525B (zh) 2014-07-07 2020-04-11 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
CA3002632C (fr) * 2015-10-29 2023-08-29 Aska Pharmaceutical Co., Ltd. Derive pyrimidine
JP7237002B2 (ja) * 2017-08-30 2023-03-10 あすか製薬株式会社 ピリミジン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514195A (ja) * 1996-12-05 2002-05-14 アムジエン・インコーポレーテツド 置換ピリミジン化合物およびそれの使用

Also Published As

Publication number Publication date
EP1136485A1 (fr) 2001-09-26
AR028282A1 (es) 2003-04-30
WO2001070726A1 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002221047A1 (en) Quinazolinone derivatives
AU2002216028A1 (en) Novel carbamate-substituted pyrazolopyridine derivatives
AU2002221827A1 (en) Novel lactame-substituted pyrazolopyridine derivatives
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2002212436A1 (en) Quinazoline derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2001292137A1 (en) Quinazoline derivatives
AU2001242523A1 (en) Aminophenyl pyrimidone derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002362806A1 (en) Pyrimidine derivatives
AU2001267852A1 (en) Novel pyrazinone derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001254731A1 (en) Substituted phenyluracils
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives